Watchlist

Watchlist
Apollo Endosurgery, Inc. (APEN)
Apollo Endosurgery, Inc. (APEN)
Your Daily Pharma Scoop: Acadia Valuation, Galectin Plunges, Revance Positive Result
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea…
Midday Gainers / Losers
Gainers: APEN +53% . CREG +33% . OHGI +20% . OTCPK:OMNT +21% . COOL +16% . TEUM +14% . SMIT +14% . THO +13% . QNST +12% . OTCQB:MRDN +11% . More news on: Apollo Endosurgery, China Recycling Energy Corporation, One Horizon Group, Inc., Stocks on t…
Premarket Gainers as of 9:05 am
APEN +35% as FDA clears Apollo's new endoscopic suturing system. More news on: Apollo Endosurgery, Pareteum Corporation, Christopher & Banks Corporation, Stocks on the move, Read more …
After Hours Gainers / Losers
Top gainers: APEN +26.5% . THO +10.4% . SRRA +9.4% . WGO +5.1% . TECD +4.6% . More news on: Apollo Endosurgery, Thor Industries, Inc., Sierra Oncology, Inc., Stocks on the move, Read more …
Apollo Endosurgery Receives FDA Clearance for OverStitch(TM) Sx Endoscopic Suturing System
Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S. Food and Drug Administration 510k clearance of the OverStitch Sx, a new, full-thickness flexible endoscopic …
Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference
Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 29 th Annual Piper Jaffray Healthcare Conference on November 28, 2017 at 8:50 am…
David C. Pacitti Joins Apollo Endosurgery Board of Directors
The Board of Directors of Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), today announced the appointment of David C. Pacitti as an independent director of Apollo. He will commence service on December 8, 2017. Mr. Pacittis appointment expands the Board of Directo…
Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d…
Apollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeek
Includes retrospective analysis of over 32,000 ORBERA cases demonstrating strong safety and efficacy of intragastric balloon therapy Apollo Endosurgery, Inc. (Apollo) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal p…
Apollo Endosurgery's (APEN) CEO Todd Newton on Q3 2017 Results - Earnings Call Transcript
Apollo Endosurgery Inc. (APEN) Q3 2017 Earnings Conference Call October 26, 2017 17:00 ET Executives Zack Kubow - IR, The Ruth Group Todd Newton - CEO Stefanie Cavanaugh - CFO Analysts Matt Hewitt - Craig-Hallum Capital Group Presentation Operator Good day and wel…
Apollo Endosurgery beats by $0.08, misses on revenue
Apollo Endosurgery (NASDAQ: APEN ): Q3 EPS of -$0.32 beats by $0.08 . Revenue of $16.5M (+4.4% Y/Y) misses by $0.16M . Press Release More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, ,
Apollo Endosurgery, Inc. (APEN)